Vita 34 AG
XETRA:V3V
Vita 34 AG
Net Income (Common)
Vita 34 AG
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita 34 AG
XETRA:V3V
|
Net Income (Common)
-€24.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Net Income (Common)
€499m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-5%
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Net Income (Common)
-€594m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Net Income (Common)
HK$131.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
Synlab AG
XETRA:SYAB
|
Net Income (Common)
€92.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Net Income (Common)?
Net Income (Common)
-24.9m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Net Income (Common) amounts to -24.9m EUR.
What is Vita 34 AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-69%
Over the last year, the Net Income (Common) growth was -69%.